Bioinformatics Outsourcing for Life Sciences: India Opportunity

ValueNotes Database Pvt. Ltd.
December 12, 2007
90 Pages - SKU: VN1635886
License type:
Table of Contents Search inside this report Related Reports
Countries covered: India

Research companies around the world now feel the need for enormous computing and data management competencies to sequence and categorize data generated by drug-discovery labs. To facilitate the storage, management, retrieval, and analysis of this large-scale data, the application of IT to the life sciences sector - bioinformatics, assumes increasingly higher significance. The use of bioinformatics tools lowers costs, improves efficiency and reduces development-to-launch timelines. The drive to further reduce R&D costs by off-shoring to low cost destinations is fuelling the outsourcing of bioinformatics services from India. This report, based on a study conducted by ValueNotes and KnowGenix, examines the bioinformatics services outsourcing market in India for the life sciences space.

According to Arun Jethmalani, CEO, ValueNotes, ""Outsourcing to India, compared to other developed countries, offers about 30-40% costs savings in overall drug discovery research, and close to 60% cost savings when outsourcing core bioinformatics services. This is owing to the lower wage costs for skilled manpower, and lower infrastructure costs.""

ValueNotes estimates that India's bioinformatics services outsourcing revenues are about USD 32 million, and are expected to grow at a CAGR of 25% touching USD 62 million by 2010. India has emerged as an attractive destination for outsourcing bioinformatics services owing to availability of low cost English-speaking manpower, lower capital and operational costs, and its established success as an IT and pharma outsourcing hub. ""Vendors, that lack international visibility for their products, are rapidly building service capabilities to capitalize on the India advantage. Pure play companies offer specialized services, IT companies offer services across the life sciences vertical while domestic life sciences companies are offering a complete research solution that includes bioinformatics services"", says Dr Raj Rajagopal, CCO KnowGenix.

The Indian vendor landscape for bioinformatics services outsourcing is made up of:
  • Pure bioinformatics companies like Strand Life Sciences, Molecular Connections, VLife Sciences Technologies
  • Domestic IT companies like Infosys, HCL Technologies, TCS
  • Domestic companies with focus on CRAMS like Jubilant Biosys, Avesthagen, GVK Biosciences
  • Multinational IT companies like Mphasis, IBM India
  • Multinational Pure bioinformatics companies like Cytogenomics, LabVantage
Going forward, we expect vendors to explore alliances or acquisitions to broaden their product/service portfolio, customer base, and geographical reach. Currently, vendors are actively seeking alliances that complement their core competencies and allow them to use emerging technologies in a mutually beneficial and cost competitive manner. Partnering strategies like licensing arrangements, marketing arrangements, and collaborative product development and research partnerships will be increasingly undertaken. According to Suchita Chaudhari, Senior Analyst at ValueNotes, ""We believe companies offering an integrated services portfolio will enjoy an upper hand, compelling pure play vendors offering only discovery informatics to expand into clinical trials informatics, and / or life sciences research to remain competitive.""

A critical success factor for India as a rising destination for outsourcing bioinformatics services is the availability of quality manpower. ""India is facing a shortage of experienced bioinformatics professionals, which is resulting in higher attrition and rising wage levels. These in turn could reduce the cost competitiveness of India over her other counterparts in China, Brazil, Ireland, etc. Government and private initiatives to boost industry-academia interaction, and corporate training initiatives are a step in the right direction,"" believes Poonam Bhana, Analyst, ValueNotes

The report provides an overview of the buyer scenario and an in-depth analysis of the Indian vendor space along with profiles of major industry players. The report is designed to help:
  • Research companies looking to outsource/off-shore bioinformatics services
  • Global biotechnology and pharmaceutical companies to gain understanding of the Indian bioinformatics vendor space
  • Outsourcing consultants to evaluate and compare offerings of Indian bioinformatics vendors
  • Potential vendors to assess opportunities in India
  • Bioinformatics vendors to assess the competitive environment in India
  • Venture capital companies looking for investment opportunities
  • Researchers looking for detailed information on Bioinformatics services off-shoring to India
This study, by ValueNotes / KnowGenix, is based on extensive interviews with key bioinformatics vendors in India, supplemented with knowledge from secondary sources.


More India Drug Discovery Reports

Clinical Trials Market in India 2012 by Netscribes (India) Pvt. Ltd.
The Indian clinical trials market is growing at an excellent rate and currently witnessing a large number of global pharmaceutical companies outsourcing trials to contract ...

Clinical Trials in India by Cygnus Business Consulting and Research
Clinical Trial industry in India touched US$400 million in 2010 and is expected to touch US$1.09 billion by 2014. Clinical Trials market in India ...

Indian Contract Manufacturing - A Hot Opportunity by RNCOS
The global pharmaceutical contract manufacturing industry has registered strong growth during the past few years. Amongst many other countries adopting the model, India has emerged ...

Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials by GBI Research
Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials Summary GBI Research’s new report, “Emerging ...

Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential by GBI Research
Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential Summary GBI Research, the leading business ...

See all reports like this >>

More India Reports

D&B Country RiskLine Report: India by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: India by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report India January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Spirits - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Datamonitor's Spirits - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...

Wine - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...

See all reports like this >>

 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Drug Discovery Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!